These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7611135)

  • 1. FDA inspections of pharmacies: what should you do?
    Gibbs JN
    Am Pharm; 1995 May; NS35(5):32-3, 35. PubMed ID: 7611135
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 3. Are independent pharmacies in need of special care? An argument against an antitrust exemption for collective negotiations of pharmacists.
    Rosenthal DB
    Yale J Health Policy Law Ethics; 2013; 13(1):198-252. PubMed ID: 23815043
    [No Abstract]   [Full Text] [Related]  

  • 4. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing regulations related to medication management, pharmacy practice initiatives, complexity of health-systems, available resources, and patient safety.
    Falk KV
    J Pharm Pract; 2010 Dec; 23(6):592-3. PubMed ID: 21507868
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication abortion: Potential for improved patient access through pharmacies.
    Raifman S; Orlando M; Rafie S; Grossman D
    J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public policy implications of cross-border Internet pharmacies.
    Cohen JC
    Manag Care; 2004 Mar; 13(3 Suppl):14-6. PubMed ID: 15074164
    [No Abstract]   [Full Text] [Related]  

  • 8. Compounding errors.
    Drazen JM; Curfman GD; Baden LR; Morrissey S
    N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
    [No Abstract]   [Full Text] [Related]  

  • 9. Policing the "wild west" world of Internet pharmacies.
    Rost KT
    Spec Law Dig Health Care Law; 2002 Jan; (273):9-29. PubMed ID: 11881538
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulators faulted for inadequate compounding pharmacy oversight.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 12. PreScription: 2017--Some Good Things Happened and Some Others.
    Allen LV
    Int J Pharm Compd; 2018; 22(1):4. PubMed ID: 29385380
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 14. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-prescribing medication: regulating prescription drug sales on the Internet.
    Yoo K
    John Marshall J Comput Inf Law; 2001; 20(1):57-89. PubMed ID: 16331879
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy practice developments: the potential impact on pharmacists' legal liability.
    Hattingh L; Forrester K; Smith N; Searle J
    J Law Med; 2007 Feb; 14(3):397-402. PubMed ID: 17355101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating compounding pharmacies.
    Noble A
    NCSL Legisbrief; 2015 Jun; 23(23):1-2. PubMed ID: 26137607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of new clinical lab rules on your pharmacy.
    Rucker NL
    Am Pharm; 1992 Jul; NS32(7):5. PubMed ID: 1642165
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176
    [No Abstract]   [Full Text] [Related]  

  • 20. Finance issue brief: any willing provider: year end report-2002.
    Morgan R; MacEachern L
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-10. PubMed ID: 12884878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.